Tag

Addyi, also known as flibanserin, was studied in more than 11,000 women before it was approved. Today, the company announced it is being acquired for $1 billion in cash by Valeant Pharmaceuticals, a multinational firm.

Sprout bought it from a German company which had given up after the FDA rejected an application in 2010.

The drug will also bear a boxed warning that women should not drink or take certain types of other medications, including antifungal drugs, because of an interaction that can cause low blood pressure and fainting.

The FDA followed that recommendation earlier this week, approving Addyi with a boxed warning and other safety measures to address side effects like dizziness, low blood pressure and fainting. “I’m hopeful not only for what it could mean for women in which it could...

Sprout Pharmaceuticals, the maker of Addyi the drug known as Female Viagra will be purchased by Valeant Pharmaceuticals for approximately $1 billion in cash, both companies announced Thursday. Sale of the company’s libido drugs will begin in October, under the brand name Addyi.

This has prompted the FDA to require the drug’s manufacturer to include a strong “boxed warning” to notify patients who drink alcohol and have liver problems not to take Addyi.